Top Sell
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Merck KGaA | 3 | 1 | 0 | 0 | €152.15 | €146.00 | -4.042% |
| Formycon AG | 3 | 1 | 0 | 0 | €43.55 | €100.00 | 129.621% |
| Bristol-Myers Squibb | 11 | 3 | 1 | 0 | €40.88 | €67.64 | 65.478% |
| Ionis Pharmaceuticals Inc. | 17 | 5 | 4 | 0 | €38.98 | €56.86 | 45.875% |
| Cytomx Therapeutics Inc | 2 | 2 | 2 | 2 | €4.12 | €50.00 | 1112.415% |
| Corbus Pharmaceuticals Holding Inc. | 2 | 1 | 2 | 0 | €35.60 | €50.00 | 40.449% |
| Roche Holding AG ADR | 2 | 1 | 0 | 0 | €27.72 | €38.00 | 37.074% |
| B.R.A.I.N. Biotechnology Research and Information Network AG | 1 | 1 | 0 | 0 | €2.82 | €30.00 | 963.830% |
| Sage Therapeutics Inc. | 5 | 3 | 1 | 1 | €12.96 | €26.71 | 106.133% |
| Evotec SE | 4 | 1 | 0 | 0 | €9.79 | €21.50 | 119.724% |
| Palisade Bio Inc. | 3 | 1 | 2 | 0 | €0.34 | €21.06 | 6072.333% |
| Moleculin Biotech Inc | 3 | 27 | 1 | 2 | €0.41 | €18.42 | 4393.659% |
| Ocuphire Pharma Inc. | 5 | 1 | 0 | 0 | €1.73 | €18.30 | 957.572% |
| Elanco Animal Health Inc. | 6 | 3 | 0 | 0 | €12.58 | €15.50 | 23.282% |
| Cyclacel Pharmaceuticals Inc. | 2 | 12 | 1 | 0 | €0.22 | €14.66 | 6565.591% |
| AEterna Zentaris Inc. | 3 | 20 | 0 | 2 | €1.87 | €14.02 | 649.759% |
| Novavax Inc. | 4 | 2 | 1 | 0 | €4.57 | €12.00 | 162.812% |
| Bluebird Bio Inc. | 4 | 6 | 0 | 0 | €0.84 | €8.82 | 955.999% |
| Trevena Inc. | 1 | 14 | 0 | 3 | €0.33 | €8.37 | 2446.849% |
| Agenus Inc. | 2 | 2 | 0 | 0 | €0.41 | €7.30 | 1664.911% |
| Minerva Neurosciences Inc. | 1 | 5 | 0 | 0 | €2.26 | €7.00 | 209.735% |
| Bayer AG ADR | 1 | 1 | 0 | 0 | €6.70 | €7.00 | 4.478% |
| Larimar Therapeutics Inc. | 2 | 4 | 0 | 0 | €6.90 | €7.00 | 1.449% |
| Gritstone Oncology Inc | 2 | 2 | 0 | 0 | €0.89 | €6.53 | 632.586% |
| Arca Biopharma | 1 | 22 | 1 | 2 | €3.26 | €6.00 | 84.049% |